Výsledky vyhledávání - "Sarah Lehnerts"

CaboRISE: A phase II study evaluating reduced starting dose and dose escalation of cabozantinib as second-line therapy for advanced HCC in patients with compensated liver cirrhosis

Autor: Stefan Pluntke, Ursula Ehmer, Oliver Waidmann, Daniel Pink, Sarah Lehnerts, Michael Geißler, Florian van Boemmel, Johanna Riedel, Jörg Trojan, Christina Kopp, Fabian Finkelmeier, Thorsten Oliver Goetze, Lutz Jacobasch

Publikováno v: Journal of Clinical Oncology. 39:TPS4163-TPS4163

TPS4163 Background: The multi-targeted tyrosine kinase inhibitor cabozantinib is approved for the treatment of advanced hepatocellular carcinoma (HCC) in adults, who have previously been treated with sorafenib. In the pivotal phase 3 CELESTIAL trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7ad93eab743e56d2faed662636166960
https://doi.org/10.1200/jco.2021.39.15_suppl.tps4163

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání